[Vienna, July 20, 2023] A number of studies have already shown that malnutrition during pregnancy may increase the risk of developing type 2 diabetes later on in life. According to a 2013 study by Peter Klimek and his team, people born during a famine have more than twice the risk of diabetes compared to those born one year earlier or later.
Up to 78 percent increase
Now, for the first time, Klimek and his team have succeeded in measuring not only the total number of diabetes cases (prevalence), but also the incidence, or the number of new cases, in a recent study.
“Among men born during the two most severe famine periods, 1939 and 1946/1947, the rate of new cases of diabetes is up to 78 percent higher in 2013 to 2017 than in comparable years, and up to 59 percent higher among women,” explains Klimek, from the Complexity Science Hub and the Medical University of Vienna. The effect is strongest in those born in 1939.
The incidence rate rose from 3.9 percent to 6.9 percent among men and from 3.4 percent to 5.4 percent among women. Additionally, both groups have an increased incidence of concomitant conditions such as heart failure, arterial hypertension, chronic obstructive pulmonary disease (COPD), and kidney disease.
Genetic programming
Scientists believe this is a result of genetic programming that occurs during pregnancy, which increases the risk of these diseases. As a result of deficiency, the unborn child’s metabolism adjusts to a nutritionally poor environment. If this does not prove true later in life, a maladaptation occurs that leads to increased metabolic and cardiovascular diseases in these birth groups.
Good data set
“One strength of our study is the new, large dataset on which it is based,” says Klimek. This covers 99.9 percent of the Austrian population between 2012 and 2017, and all insured patients aged over 50 and under 100 were examined. Of these approximately 3.5 million people, 746,184 were treated for diabetes. The comprehensive dataset allowed researchers to measure age-specific and regional incidence rates directly for the entire population, without additional assumptions that would be required for modeling.
“Our results clearly demonstrate that public health efforts to address diabetes should not focus solely on lifestyle factors. The importance of reproductive health, as well as adequate nutrition during pregnancy and in the early postnatal period, must also be considered,” Klimek said.
_____
Find out more
The study “Diabetes incidence in Austria: The role of famines on diabetes and related NCDs” by Michaela Kaleta, Michael Leutner, Stefan Thurner, Alexander Kautzky, Gottfried Endel, Noemi Kiss, Martin Robausch, Alexandra Kautzky-Willer, and Peter Klimek, was published in Heliyon Volume 9, Issue 7, July 2023, e17570.
_____
About the Complexity Science Hub
The mission of the Complexity Science Hub (CSH) is to host, educate, and inspire complex systems scientists dedicated to making sense of Big Data to boost science and society. Scientists at the Complexity Science Hub develop methods for the scientific, quantitative, and predictive understanding of complex systems.
The CSH is a joint initiative of the Austrian Institute of Technology (AIT), Central European University (CEU), University for Continuing Education Krems, Graz University of Technology, Medical University of Vienna, TU Wien, VetMedUni Vienna, Vienna University of Economics and Business, and Austrian Economic Chambers (WKO). https://www.csh.ac.at
Journal
Heliyon
Method of Research
Data/statistical analysis
Subject of Research
People
Article Title
Diabetes incidence in Austria: The role of famines on diabetes and related NCDs
Article Publication Date
4-Jul-2023
COI Statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Peter Klimek reports financial support was provided by Vienna Science and Technology Fund under MA16-045. Alexandra Kautzky-Willer reports a relationship with Eli Lilly and Company that includes: speaking and lecture fees. Alexandra Kautzky-Willer reports a relationship with Boehringer Ingelheim GmbH that includes: speaking and lecture fees. Alexandra Kautzky-Willer reports a relationship with Novo Nordisk Inc that includes: speaking and lecture fees.